TERIPARATIDE
Drug
Alvogen Inc
Total Payments
$79,272
Transactions
3,986
Doctors
2,168
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $49,636 | 2,474 | 1,508 |
| 2023 | $18,010 | 896 | 614 |
| 2022 | $10,464 | 553 | 399 |
| 2021 | $1,162 | 63 | 61 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $79,272 | 3,986 | 100.0% |
Top Doctors Receiving Payments for TERIPARATIDE — Page 87
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Student in an Organized Health Care Education/Training Program | Houston, TX | $12.24 | 1 |
| , M.D | Endocrinology, Diabetes & Metabolism | Arlington, TX | $12.16 | 1 |
| Elana Gersten | Physician Assistant | New York, NY | $12.15 | 1 |
| , MD | Family Medicine | Torrance, CA | $12.15 | 1 |
| , M.D | Rheumatology | Dallas, TX | $12.15 | 1 |
| , M.D | Orthopaedic Surgery | Loma Linda, CA | $12.11 | 1 |
| , M.D | Psychiatry | Las Vegas, NV | $12.07 | 1 |
| , M.D | Internal Medicine | Alhambra, CA | $12.02 | 1 |
| , D.O | Psychiatry | Houston, TX | $11.97 | 1 |
| , D.O | Endocrinology, Diabetes & Metabolism | Marshall, TX | $11.97 | 1 |
| , M.D | Family Medicine | La Porte, TX | $11.97 | 1 |
| , M.D | Endocrinology, Diabetes & Metabolism | Monroe, MI | $11.92 | 1 |
| , NP | Family | Holland, OH | $11.92 | 1 |
| , PA-C | Physician Assistant | Toledo, OH | $11.92 | 1 |
| , M.D | Obstetrics & Gynecology | Sugar Land, TX | $11.73 | 1 |
| , MD | Rheumatology | Dover, DE | $11.50 | 1 |
| , M.D | Internal Medicine | Los Angeles, CA | $11.43 | 1 |
| , MD | Internal Medicine | Bloomington, IN | $11.07 | 1 |
| , D.O | Family Medicine | Sacramento, CA | $7.36 | 1 |
Ad
Manufacturing Companies
- Alvogen Inc $48,620
- Almatica Pharma LLC $30,653
Product Information
- Type Drug
- Total Payments $79,272
- Total Doctors 2,168
- Transactions 3,986
About TERIPARATIDE
TERIPARATIDE is a drug associated with $79,272 in payments to 2,168 healthcare providers, recorded across 3,986 transactions in the CMS Open Payments database. The primary manufacturer is Alvogen Inc.
Payment data is available from 2021 to 2024. In 2024, $49,636 was paid across 2,474 transactions to 1,508 doctors.
The most common payment nature for TERIPARATIDE is "Food and Beverage" ($79,272, 100.0% of total).